GSK RSV vaccine secures age indication expansion from US FDA
(Alliance News) - GSK PLC on Friday said its respiratory syncytial virus vaccine, Arexvy, has gained an age indication expansion from the US Food & Drug Administration. Read More
| Price | 2,052.00p on 13-03-2026 at 14:21:06 |
|---|---|
| Change | 21.00p 1.03% |
| Buy | 2,052.00p |
| Sell | 2,051.00p |
| Last Trade: | Buy 40.00 at 2,052.00p |
| Day's Volume: | 4,221,841 |
| Last Close: | 2,031.00p |
| Open: | 2,029.00p |
| ISIN: | GB00BN7SWP63 |
| Day's Range | 2,027.00p - 2,062.00p |
| 52wk Range: | 1,242.50p - 2,282.00p |
| Market Capitalisation: | £82.21b |
| VWAP: | 2,034.90794p |
| Shares in Issue: | 4.01b |
Glaxosmithkline (GSK) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 40 | 2,052.00p | Automatic Execution |
14:20:50 - 13-Mar-26 |
| Buy* | 98 | 2,052.00p | Automatic Execution |
14:20:50 - 13-Mar-26 |
| Buy* | 231 | 2,052.00p | SI Trade |
14:20:35 - 13-Mar-26 |
| Unknown* | 0 | 2,049.00p | SI Trade |
14:19:53 - 13-Mar-26 |
| Buy* | 2 | 2,051.00p | SI Trade |
14:19:45 - 13-Mar-26 |
| Buy* | 194 | 2,051.00p | Automatic Execution |
14:19:28 - 13-Mar-26 |
| Buy* | 2,375 | 2,051.00p | Automatic Execution |
14:19:27 - 13-Mar-26 |
| Buy* | 22 | 2,051.00p | Automatic Execution |
14:19:25 - 13-Mar-26 |
| Buy* | 31 | 2,051.00p | Automatic Execution |
14:19:25 - 13-Mar-26 |
| Buy* | 21 | 2,051.00p | Automatic Execution |
14:19:25 - 13-Mar-26 |
Glaxosmithkline (GSK) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 12th Mar 2026 7:00 am | RNS | Transaction in Own Shares |
| 11th Mar 2026 7:00 am | RNS | Transaction in Own Shares |
| 11th Mar 2026 7:00 am | RNS | Transaction in Own Shares |
| 10th Mar 2026 7:00 am | RNS | Transaction in Own Shares |
| 9th Mar 2026 3:00 pm | RNS | Board Committee Change |
| 9th Mar 2026 3:00 pm | RNS | Board Committee Change |
| 9th Mar 2026 7:00 am | RNS | GSK and Alfasigma agree global linerixibat rights |
| 9th Mar 2026 7:00 am | RNS | Transaction in Own Shares |
| 6th Mar 2026 2:21 pm | RNS | Filing of GSK plc 2025 Annual Report on Form 20-F |
| 6th Mar 2026 7:00 am | RNS | Transaction in Own Shares |